SCHEMBL5850598

SCHEMBL5850598

COC(=O)c1ccccc1S(=O)(=O)NC(C)(C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.48
ACE P12821 2/20 0.47
MME P08473 2/20 0.47
ACE2 Q9BYF1 1/20 0.47
ALDH1A1 P00352 2/20 0.45
MAPT P10636 1/20 0.45
POLB P06746 1/20 0.44
GAA P10253 2/20 0.43
CA2 P00918 2/20 0.43
CA1 P00915 1/20 0.43
CA5A P35218 1/20 0.43
CA9 Q16790 1/20 0.43
NPC1 O15118 1/20 0.43
FPR2 P25090 1/20 0.42
KMT2A Q03164 1/20 0.42
MMP2 P08253 4/20 0.41
MMP9 P14780 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ADAMTS4 O75173 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27541181 1.00 NPSR1 (0.48) NPSR1ACEMMEACE2ALDH1A1
SCHEMBL5573305 0.81 ACE (0.45) ACEALDH1A1MAPTPOLBGAA
SCHEMBL27514797 0.81 ACE (0.45) ACEALDH1A1MAPTPOLBGAA
SCHEMBL27534943 0.81 POLB (0.50) ACEMMEACE2ALDH1A1MAPT
SCHEMBL5570713 0.81 POLB (0.50) ACEMMEACE2ALDH1A1MAPT
SCHEMBL7416066 0.75 MME (0.47) ACEMMEACE2ALDH1A1
SCHEMBL7416062 0.75 MME (0.47) ACEMMEACE2ALDH1A1
SCHEMBL7416059 0.74 MME (0.45) ACEMMEACE2ALDH1A1CA2
SCHEMBL7416053 0.74 MME (0.45) ACEMMEACE2ALDH1A1CA2
SCHEMBL12863002 0.73 NPSR1 (0.69) NPSR1ACEMMEACE2FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030114-B1 Compounds which inhibit leukocyte adhesion mediated by VLA-4 ELAN PHARMACEUTICALS, INC. (US) 2006-04-18 US disclosed
EP-0994895-A1 DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-04-26 EP disclosed
WO-1999006435-A1 DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed